Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Sign Up to like & getrecommendations! Published in 2017 at "Biomarker Research"
DOI: 10.1186/s40364-017-0093-8
Abstract: We have seen a notable increase in the application of PD-1/PD-L1 inhibitors for the treatment of several solid and hematogenous malignancies including metastatic melanoma, non-small-cell lung cancer and lymphoma to name a few. The need… read more here.
Keywords: utility immunohistochemistry; response; utility; assays predicting ... See more keywords